" class="no-js "lang="en-US"> Jürgen Eckhardt - Medtech Alert
Wednesday, January 15, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Jürgen Eckhardt

Jürgen Eckhardt

About Jürgen Eckhardt

Related Story

Fundraising

 Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing | Pharmtech Focus

Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing

January 27 2022

Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]

Fundraising

 Bloom Science Raises USD $12 Million in Series A Financing | Pharmtech Focus

Bloom Science Raises USD $12 Million in Series A Financing

December 10 2021

San Diego based biotech company Bloom Science announced today it successfully closed a USD $12 Million Series A […]

Fundraising

 Ada Health Secures £63m Investment to Enhance Assessment Tech | Pharmtech Focus

Ada Health Secures £63m Investment to Enhance Assessment Tech

June 2 2021

Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]

Fundraising

 Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health | Pharmtech Focus

Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health

May 28 2021

Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]